Arax Advisory Partners’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$115K Sell
1,165
-29
-2% -$2.82K ﹤0.01% 2724
2026
Q2
$111K Buy
1,194
+1,166
+4,164% +$110K ﹤0.01% 2651
2026
Q1
$2.49K Buy
28
+23
+460% +$2.36K ﹤0.01% 3043
2025
Q4
$476 Buy
+5
New +$504 ﹤0.01% 3619
2025
Q3
– Sell
-10
Closed -$1.06K – 3675
2025
Q2
$1.06K Buy
+10
New +$1.01K ﹤0.01% 2753

Other funds holding BNTX

Arax Advisory Partners's BNTX Position: Q3 2026 in Review

Arax Advisory Partners reduced its BioNTech (BNTX) stake by 2.4% in Q3 2026, selling an estimated $2.82K and leaving 1,165 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #2724.

Arax Advisory Partners first reported a position in BNTX in Q2 2025 and has held it in 5 quarters since. 302 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • Arax Advisory Partners held 1,165 shares of BioNTech worth $115K as of Q3 2026.
  • Arax Advisory Partners sold 29 BioNTech shares in Q3 2026, an estimated $2.82K.
  • BioNTech made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #2724 holding.
  • Arax Advisory Partners first reported a position in BioNTech in Q2 2025 and has held it in 5 quarters since.
  • 302 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.